Next Article in Journal
Acute Kidney Injury in the ICU during Ganciclovir Treatment, an Observational Study
Previous Article in Journal
Body Stalk Anomaly Complicated by Ectopia Cordis: First-Trimester Diagnosis of Two Cases Using 2- and 3-Dimensional Sonography
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 12
Issue 5
10.3390/jcm12051897
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Symptomatic Outcomes of Cholecystectomy for Gallstones

by
Daniel Mønsted Shabanzadeh
Department of Surgery, Nordsjaellands Hospital Hilleroed, Dyrehavevej 29, DK-3400 Hilleroed, Denmark
J. Clin. Med. 2023, 12(5), 1897; https://doi.org/10.3390/jcm12051897
Submission received: 7 February 2023 / Revised: 22 February 2023 / Accepted: 26 February 2023 / Published: 28 February 2023
(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
Versions Notes

Abstract

:
Cholecystectomy is the definite treatment for symptomatic gallstones, and rates are rapidly rising. Symptomatic complicated gallstones are generally treated with cholecystectomy, but there is no consensus on the clinical selection of patients with symptomatic uncomplicated gallstones for cholecystectomy. The aim of this review is to describe symptomatic outcomes before versus after cholecystectomy in patients with symptomatic gallstones as reported in prospective clinical studies and to discuss patient selection for cholecystectomy. Following cholecystectomy, resolution of biliary pain is high and reported for 66–100%. Dyspepsia has an intermediate resolution of 41–91% and may co-exist with biliary pain but may also develop following cholecystectomy with an increase of 150%. Diarrhea has a high increase and debuts in 14–17%. Persisting symptoms are mainly determined by preoperative dyspepsia, functional disorders, atypical pain locations, longer duration of symptoms, and poor psychological or physical health. Patient satisfaction following cholecystectomy is high and may reflect symptom alleviation or a change in symptoms. Comparison of symptomatic outcomes in available prospective clinical studies is limited by variations in preoperative symptoms, clinical presentations, and clinical management of post-cholecystectomy symptoms. When selecting patients with biliary pain only in a randomized controlled trial, 30–40% still have persisting pain. Strategies for the selection of patients with symptomatic uncomplicated gallstones based on symptoms alone are exhausted. For the development of a selection strategy, future studies should explore the impact of objective determinants for symptomatic gallstones on pain relief following cholecystectomy.

1. Introduction

Cholecystectomy is currently the only definite treatment for symptomatic gallstones. Cholecystectomy rates have been rapidly rising in European countries within the past decades [1,2] and possibly also in pediatric populations [3]. Treatment of gallstones and cholecystectomy generally cause high healthcare costs [4]. High proportions of persistent symptoms and pain following cholecystectomy have previously been reported when reviewing prospective clinical studies [5], indicating impaired clinical guidelines and practice. This review provides an update on the symptomatic outcomes of cholecystectomy for symptomatic gallstones and discusses the selection of patients for surgery.
Gallstones are highly prevalent in general populations of the US and Europe and depend largely on ethnicity, age, and female sex [6]. The natural course of gallstones has been explored in one cohort, which included people with ultrasound screen-detected gallstones and who remained uninformed of their gallstone status. Only 18% developed symptomatic gallstones requiring hospital admission during long-term follow-up, and about half were due to symptomatic uncomplicated gallstones. The conclusion was that the natural course of gallstones is less aggressive than previously anticipated and that the vast majority of prevalent gallstones remain clinically silent and require no further treatment [7]. The current clinical challenge is selecting the right patients with symptomatic uncomplicated gallstones who will benefit the most from cholecystectomy.
The symptomatic complicated gallstones include acute cholecystitis, common bile duct stones, cholangitis, and pancreatitis while the uncomplicated include symptomatic gallstones in the absence of complications [8]. Cholecystectomy is recommended for all complicated gallstones [9,10,11,12,13,14]. In presence of symptomatic uncomplicated gallstones, current clinical practice guidelines have no consensus on which symptoms or patient characteristics should guide selection for cholecystectomy [9,10,11,12,14,15]. A randomized controlled trial of observation versus cholecystectomy concluded that the non-operative strategy caused fewer symptomatic complicated gallstones during follow-up when compared to post-cholecystectomy complications. Although the study proved the feasibility of observation in the presence of symptomatic uncomplicated gallstones [16], long-term follow-up of the population also showed cholecystectomy to be the preferred treatment [17]. Most practice guidelines recommend cholecystectomy for symptomatic uncomplicated gallstones [9,10,11,12,14], while observation is either disregarded [9] or only suggested [13]. The pooled postoperative morbidity following cholecystectomy is reported to be 1.6–5.3%, including bile duct injuries in 0.32–0.52% [18].
Etiologies for post-cholecystectomy symptoms have recently been systematically reviewed and pooled into (1) co-existent diseases such as gastroesophageal reflux, peptic ulcer, or functional disorders; (2) physiological changes including duodenogastric reflux causing gastritis or bile acid malabsorption causing diarrhea; (3) retained or newly formed gallstones; (4) sphincter of Oddi dysfunction; (5) psychological distress; or (6) surgical complications such as common bile duct injury or incisional hernia. Symptoms may debut, but most often they persist [19]. Common bile duct stones may present with symptoms within 6 days to 18 years following laparoscopic cholecystectomy [20]. Gallstones may also be retained or newly formed in remnants of the cystic duct following cholecystectomy or of the gallbladder following a subtotal cholecystectomy. Estimates for complications due to retained or newly formed gallstones following cholecystectomy are reported with wide ranges between studies [19]. Although there are many possible reasons for post-cholecystectomy symptoms, a third of patients have no identified causes [21].
Several study limitations may bias estimates of symptomatic outcomes following cholecystectomy in published clinical studies. The risk of bias may be due to either uncontrolled estimates without preoperative symptom assessment [22,23,24,25,26,27] or to retrospective assessments following surgery with a risk of recall bias [28,29]. On the other hand, estimates from prospective clinical studies may be limited by the short duration of follow-up [30,31,32,33]. Both retrospective and prospective studies may have a risk of attrition bias with either high or unreported proportions of patients lost to follow-up [34,35,36] or otherwise incomplete postoperative assessments such as unanswered questionnaires [37].
This review describes symptomatic outcomes before versus after cholecystectomy in patients with symptomatic gallstones. The focus is on declines or inclines in the proportion of patients with symptoms, on the debut of symptoms, and on the determinants of post-cholecystectomy symptoms as reported in prospective clinical studies.

2. Biliary Pain Definitions and Determinants

Symptoms of biliary pain ascribed to gallstones have traditionally been termed “biliary colic” by pioneers in medical practice such as Sir William Osler. The original symptom complex was defined by a sudden debut, of intense and agonizing pain, localized in the right hypochondrium or epigastrium, with projection to the shoulder, and a duration of hours to days or possibly even weeks [38]. Similar but more simple definitions of biliary pain were later accepted in a series of gallstone screening studies in Italy during the 1980–90′ies which included abdominal pain during the last five years, with a duration of more than 30 min, and localized in the right hypochondrium and/or epigastrium [39,40,41]. Most definitions of biliary pain share similarities in regard to pain localization and duration, but may also include nausea or vomiting [42,43], not being relieved by bowel movements [42,44], a possible association to food ingestion [42], and forcing one to stop all current activity, to lie down, or to take analgesics [45,46]. All these biliary pain definitions rely on expert opinions or consensus statements rather than empirical evidence (Table 1).
In studies exploring gallstone prevalence in general or clinical populations, it has generally been challenging to associate gallstones with a specific symptom or complex. Although more or less strict definitions of biliary colic have been associated with gallstone prevalence when compared to controls without gallstones, the diagnostic accuracy and predictive test values are very low [47].
Only a few determinants for the development of symptomatic gallstones have been identified when studying gallstone cohorts through long-term follow-up. In the cohort including persons uninformed and unaware of the presence of gallstones at baseline as described above, determinants for the development of symptomatic uncomplicated gallstones were pain localized in the epigastrium, with a duration of hours, of moderate to extreme intensity, and with the need for analgesics. Pain at night determined symptomatic complicated gallstones only [48]. These findings share similarities with the originally described “biliary colic”, except for pain projection. Pain projection has only been associated with gallstones in patients with emergency admissions in a cross-sectional study and with incident gallstones identified through multiple ultrasound examinations in a population-based cohort study [49,50].
Determinants for the development of symptomatic gallstones of a more objective character have also been identified in cohort studies. These include younger age, female sex, multiple gallstones [7,51], gallstone size of 1 cm or above [7,51,52], higher body mass index (BMI) [51,53], gallbladder polyps, tobacco smoking, and a number of comorbidities [51].
The mechanisms involved in subjective symptom generation are not fully understood but are believed to include a gallstone passage to the duodenum or an obstruction of the gallbladder or bile ducts causing biliary distention [38,54]. This should then activate visceral sensory neurons and create a sensation of pain [55]. In support of these long-held traditional beliefs, experimental distention of the gallbladder has been shown to cause pain in the right hypochondrium or epigastrium in patients with acute cholecystitis [56].
Table
Table 1. Definitions of biliary pain in different types of studies.
Table 1. Definitions of biliary pain in different types of studies.
Consensus-Based Definitions
Gallstone screening studies
GREPCO—Rome Group for the Epidemiology and Prevention of Cholelithiasis (1984) [39]Abdominal pain in the last five years
Duration of 30 min or more
Localized in right hypochondrium and/or epigastrium
Chianciano population study (1994) [40]
MICOL—Multicenter Italian Study on Cholelithiasis (1995) [41]
Sirmione Study (1987) [44]Same definition as [39,40,41]
+ not relieved by bowel movements
Clinical studies
Ros and Zambon (1987) [42]Steady pain in the right hypochondrium/epigastrium
Nausea or vomiting
Duration of at least one hour
Associated or not with food ingestion
Unrelated to bowel movements
Unassociated with discomfort at urination
Heaton et al. (1991) [45]Abdominal pain attacks during the last year
Duration of 30 min or more
Localized in the upper abdomen
Forces one to stop activities, lie down, or take analgesics
Martinez de Pancorbo et al. (1997) [46]Abdominal pain in the right hypochondrium and/or epigastrium
Forces one to lie down or take analgesics
Mertens et al. (2010) [43]One or more of upper abdominal pain, nausea, and vomiting
Clinical practice guidelines
NICE—National Institute for Health and Care Excellence (2014) [9]No recommendation due to lack of research
UMHS—University of Michigan Health System (2014) [14]Severe episodic pain
Localized in right upper abdominal quadrant/epigastrium
May be nocturnal
Occasionally postprandial
Possibly tenderness
EASL—European Association for the Study of the Liver (2016) [10]Episodic attacks of severe pain
Localized in right upper abdominal quadrant/epigastrium
Radiation to the right back or shoulder
Duration of at least 15–30 min
A positive response to analgesics
Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, Royal College of Surgeons (2016) [15]Pain localized in right upper quadrant/epigastrium
Frequently radiating to the back
Duration of several minutes to hours
Often occurring at night
Dutch Society for Surgery (2017) [11]Biliary colic
Radiating pain clockwise to the back
A positive response to analgesics
German Society for Digestive and Metabolic Diseases and German Society for Surgery of the Alimentary Tract (2018) [12]Pain attacks localized in right upper quadrant/epigastrium
Duration of more than 15 min
Possible projection to back and right shoulder
Possible nausea and vomiting
Data-based Definitions in Prospective Studies
Prospective cohort studies
Shabanzadeh et al. (2017) [48]Pain localized in the epigastrium
Moderate to extreme intensity
Duration of hours
Need for analgesics

3. Limitations of Studies Exploring Symptomatic Outcome

Most prospective clinical studies exploring symptomatic outcomes of cholecystectomy report results from unselected patient populations including both symptomatic complicated and uncomplicated gallstones. The latter may include symptoms of unspecified pain or other abdominal complaints, such as dyspepsia. Most of these studies of unselected populations report the presence of either biliary or unspecified pain at baseline [42,43,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79], and only a few include patients with mostly dyspepsia [58]. Exploration of selected study populations with dyspepsia as the main complaint at baseline has been performed in only a few studies [80,81,82], and one study has performed a subgroup analysis of patients with dyspepsia [43].
The identification of underlying diseases for post-cholecystectomy symptoms requires diagnostic examinations [19]. Most available studies do not report the performance of examinations at clinical follow-up or the identification of causes for post-cholecystectomy symptoms. Few studies report the performance of post-cholecystectomy cholangiography, endoscopy, ultrasound, or blood samples [42,57,59,60,62,63,65,66,69,71,83,84]. Even fewer studies report treatments for identified underlying diseases causing post-cholecystectomy symptoms before the final clinical assessments or how they managed patients in the analysis of the symptomatic outcome for cholecystectomy [42,57,66,83,84].

4. Pooled Symptoms Outcome

Most of the studies reporting pooled symptom outcomes include populations with pain at baseline [42,43,60,61,62,63,64,65,66,68,69,70,74,77,78,83,85,86,87]. Resolution of the symptom indicating cholecystectomy is reported for 44–92% [42,43,60,61,62,63,64,65,66,68,69,70,74,77,78,81,83,85,86,87,88,89,90,91,92,93]. Persisting symptoms are reported for 8–56% [42,43,60,62,63,64,65,66,68,70,74,77,78,81,83,85,86,87,88,89,90,91,92,93] and a debut of symptoms in 1–34% of patients [43,61,68,74,75,83]. The wide ranges of symptom resolution, persistence, and debut are either due to the heterogeneous selection of patients for surgery in the available study populations or to changes caused by surgery. Due to the variation in clinical presentations and baseline symptoms in study populations, the interpretation of pooled symptom outcome estimates following cholecystectomy should be cautious. On the other hand, patient satisfaction following cholecystectomy is high, with reported proportions of 66–97% [61,62,64,65,70,73,75,86,87,92,93,94]. This may indicate that, although symptoms may not be resolved completely, they may be significantly improved in most patients.
Symptom resolution is determined by a preoperative history of cholecystitis [70] and a higher age [62]. Persisting symptoms are determined by preoperative dyspeptic symptoms [63,70], symptom duration over 6 months, gastritis [93], poor self-rated health [70], higher Gastrointestinal Symptom Rating Scale, higher Hopkins Symptom Checklist for assessment of anxiety and depression [81], higher trait anxiety [43], higher Psychological Symptom Score [93], and an American Society of Anesthesiologists (ASA) score of III-IV [70]. Unsatisfying or unsuccessful cholecystectomy outcome is determined by flatulence, duration of days or more for pain episodes [59], symptom duration over 6 months, and poor self-rated health [70]. Both younger age and an age above 55 years have been associated with persisting symptoms [59,62] (Table 2). Female sex has been associated with postoperative symptoms in a retrospective study only [24].

5. Pain Outcome

Outcomes for biliary colic or otherwise defined biliary pain are the most frequently reported following cholecystectomy, with a resolution of 66–100% [42,43,57,59,60,61,62,63,64,65,66,67,68,73,74,76,78,79,97]. Biliary pain does not seem to debut in available studies [62], and no studies report an incline following cholecystectomy (Table 3).
Undefined or atypical pain is estimated with a wide range of changes following cholecystectomy, from a resolution of 41–99% [43,62,65,69,70,72,75,76,77] to an incline of 22–41% [71,74], and to a debut in 0–7% [62,69,75,84] (Table 3). Complaints of pain that cannot be defined as biliary pain may have multiple causes that co-exist but otherwise are unrelated to gallstones [19,79]. These outcome estimates should, therefore, also be interpreted with caution.
Identified determinants for pain resolution are no heartburn, lower visual analogue scale, pain attacks [78], pain awakening at night [77], pain frequency of one per month or less [77], symptom duration of one year or less [77,87], no use of pain medication, no previous abdominal surgery [78], higher Gastrointestinal Quality of Life Index [87], and higher age [77,78]. Postoperative persistence of pain is determined by dyspepsia [68], functional dyspepsia and/or irritable bowel syndrome [79], atypical pain locations or lower abdominal pain [74,77], flatulence, food intolerance [74], abnormal bowel pattern (diarrhea or constipation), often feeling bloated [77], pain attacks every month [74], and psychic vulnerability [83] (Table 2). Female sex has been associated with postoperative pain in retrospective studies only [25,26,27].

6. Dyspepsia Outcome

Dyspepsia is reported with an intermediate resolution of 41–91% [42,43,57,58,62,75,95,98] and to debut in 0–6% [58,62,75,84] following cholecystectomy in studies including unselected patient populations as described above.
Definitions of dyspepsia have been without consensus and changed much throughout time. Flatulent dyspepsia was once a multi-symptomatic syndrome thought to be caused by gallstones but was also found to be due to other disorders [99]. The more recently described functional dyspepsia is defined according to the Rome IV criteria as one or more of bothersome postprandial fullness, early satiation, epigastric pain, or burning in the absence of structural disease at endoscopy [100]. These varying and broad definitions of dyspepsia make it challenging to assess changing symptoms between studies.
It may be of more value to assess the single symptoms commonly thought to comprise the dyspepsia complex. Heartburn is reported to resolve for 43–72% of patients [57,69,70,75,76,80,93,95] and to debut in 1–8% [69,70,75]. Regurgitation or reflux resolves for 24–92% [60,62,69,74,76,80,93,95] and debuts in 2–14% [62,69,89]. Nausea resolves for 54–98% [59,60,61,65,66,69,70,72,75,76,93,97] and debuts in 0–2% [69,70,75]. Vomit resolves for 57–100% [59,65,66,69,70,74,75,76] and debuts in 0–1% [69,70,75]. Fat or food intolerance resolves for 61–100% [60,61,62,66,70,74,75,97] and debuts in 2–13% [60,62,70,75,84]. Indigestion or postprandial heaviness resolves for 41–93% [59,60,61,66,80,93]. Flatulence resolves for 29–79% [59,60,61,62,65,69,70,75,80] and debuts in 0–10% [62,69,70,75,84] (Table 3). Generally, dyspeptic symptoms have intermediate resolution in studies of unselected populations. Single studies have reported inclines for regurgitation or reflux of 37% [89], nausea of 100%, and vomiting of 243% [71]. These studies have very small-sized study populations, and the results have not been reproduced in larger studies.
In studies of populations where dyspepsia is the main complaint at baseline, a minor resolution of dyspepsia for 17–28% has been reported [80,82]; however, populations are small and highly selected. One study including a larger population undergoing elective laparoscopic cholecystectomy found a high incline of 150% in patients reporting dyspeptic symptoms without biliary symptoms following cholecystectomy (preoperative 14% versus postoperative 35%) (Table 3). In comparison, symptom relief in patients with preoperative biliary symptoms without or with dyspeptic symptoms was 88% and 77%, respectively [43]. Dyspeptic symptoms may thereby develop in unselected patient populations. Mechanisms of dyspeptic symptom development following cholecystectomy have been suggested in experimental studies and include duodenogastric reflux, histological gastritis [71,101,102,103], and impaired postprandial gastric emptying [104].
Determinants for postoperative dyspeptic symptoms are preoperative dyspepsia [43,68], non-specific symptoms, psychotropic medication [43], and a middle age range of 40–69 years when compared to the younger or older [95] (Table 2).
It seems that biliary pain and dyspeptic symptoms may co-exist, and that cholecystectomy resolves dyspeptic symptoms in unselected populations where most patients report pain at baseline. However, dyspepsia may also incline or debut following cholecystectomy. Resolution of dyspeptic symptoms in populations where they are the main preoperative complaint seems inconsistent based on the currently available studies. Larger studies exploring populations with functional dyspepsia or, alternatively, analysis of subgroups should be performed in the future. Until further, cholecystectomy is not indicated for the presence of dyspepsia only.

7. Diarrhea Outcome

Diarrhea seems to develop rather than resolve following cholecystectomy and is reported with high inclines of 40–850% [66,92,93,96,105,106] and to debut in 14–17% [84,92]. Available studies show a generally low preoperative prevalence of 2–22% [66,92,93,96,105,106] (Table 3). Determinants for postoperative diarrhea are younger age below 50 years [92,96] and higher BMI group [96] (Table 2).
Diarrhea is believed to be due to continuous bile excretion following cholecystectomy, which may also cause bile acid malabsorption [107]. Another proposed mechanism includes a shortened gut transit due to accelerated colonic passage [108]. More recently, a decreased microbial diversity in patients with post-cholecystectomy diarrhea has been demonstrated when compared to patients without diarrhea following cholecystectomy or to healthy controls [109,110].
Estimating the prevalence of post-cholecystectomy diarrhea is challenging. Bile acid malabsorption is diagnosed with a SeHCAT (selenium homocholic acid taurine) test that shows low absorption of radiolabelled bile acids. Tests are usually performed several years following cholecystectomy [111,112]. A retrospective study with a follow-up of four years has shown diarrhea to debut in 12% [108]. Prospective studies with multiple postoperative assessments report inclining proportions of patients with diarrhea within the first month following cholecystectomy, only to decline again during the following months [93,96,106,113]. Available prospective studies have a maximum follow-up duration of 12 months, which, therefore, may exaggerate the incidence of diarrhea [66,92,93,96,105,106]. A more exact prevalence of post-cholecystectomy diarrhea has yet to be explored in future clinical studies. Such studies should have longer and more systematic follow-ups of an entire cholecystectomy cohort including both symptom assessments and functional tests.

8. Other Functional Disorders Outcome

Constipation is reported with minor declines of 0–47% following cholecystectomy [66,74,93,96,105]. Mechanisms of changing bowel function following cholecystectomy, including increased colonic transit, have also been suggested to correct constipation [105,108]. However, changes in constipation following cholecystectomy are of a minor magnitude and may, until further notice, also be ascribed to random changes during follow-up.
Abdominal bloating or distention is reported to resolve for 21–73% of patients following cholecystectomy in unselected populations [59,61,65,66,74,76,97]. Bloating or distention is part of irritable bowel syndrome according to the Manning criteria [114]. It is also associated with irritable bowel syndrome and other functional bowel disorders according to the Rome IV criteria [115]. Currently, no studies have explored symptom outcomes following cholecystectomy in populations with mainly functional gastrointestinal disorders.
A recent large prospective observational study found that patients with functional dyspepsia and/or irritable bowel syndrome at baseline were significantly less likely to be pain-free six months after cholecystectomy when compared to those without (41% vs. 64%). Biliary colic was effectively resolved following cholecystectomy, independently of concomitant functional dyspepsia and/or irritable bowel syndrome [79]. Other studies have also found that patients with functional gastrointestinal disorders are less likely to resolve symptoms [85] and that patients with irritable bowel syndrome have fewer improvements in gastrointestinal quality of life scores following cholecystectomy [116]. Patients with irritable bowel syndrome have an increased risk of cholecystectomy that is not due to an increased risk of gallstones [117].
Currently, it seems that patients with mainly functional gastrointestinal disorders should be carefully selected for cholecystectomy based on the presence of biliary pain if offered surgery at all.

9. Selection of Patients for Cholecystectomy

The high rates of biliary pain resolution reported in prospective clinical studies indicate a true benefit of cholecystectomy, and it appears beneficial to select patients with biliary pain for cholecystectomy and, vice versa, refrain from surgery in its absence. A recent large randomized controlled trial, the SECURE trial, has challenged this assumption. Patients with uncomplicated gallstones and abdominal pain were selected for cholecystectomy through allocation to either a restrictive or a usual care strategy. In the usual care strategy, the selection was at the discretion of the physician. In the restrictive strategy, cholecystectomy was advised only to those patients who fulfilled a five-criteria symptom complex including (1) severe pain attacks, (2) pain duration of 15–30 min or longer, (3) pain localized in the epigastrium or right upper quadrant, (4) pain radiating to the back, and (5) a positive response to simple analgesics. If cholecystectomy was deferred accordingly at the first clinical assessment, the need was reconsidered during follow-up assessments. At one-year follow-up, only 72% versus 98% of patients allocated to the restrictive strategy were treated per protocol when compared to the usual care strategy. Thereby, a large cross-over of patients to cholecystectomy was seen in the restrictive strategy arm. The primary outcome was the proportion of patients being pain-free at follow-up, which was no different for the restrictive and usual care strategies (64% versus 63%, respectively). The only identified differences were fewer cholecystectomies in the restrictive strategy. The study concluded suboptimal pain reduction for both strategies [118]. Parallel with the SECURE trial, a prospective cohort study, the Success trial, developed a prediction model for clinically significant pain reduction following cholecystectomy, which was validated in the study population of the SECURE trial [78]. The identified determinants for pain reduction have been referred to in this present review (see Section 5 and Table 2).
The SECURE trial demonstrated the clinical challenges of withholding patients from a protocolled treatment and, even more, it challenged the definitions and predictive value of biliary pain. Despite protocolled attempts to select patients for cholecystectomy based on strict biliary pain definitions, the proportions of patients with persisting pain were unacceptably high.
Patient selection for cholecystectomy relying only on patient-reported symptoms has been clinical practice for a long time but is suboptimal if the aim is a pain-free state following surgery. Although prediction scores for symptomatic outcomes of cholecystectomy are of limited availability and even fewer are validated [78], available studies seem to have exhausted the exploration of preoperative patient-reported symptoms for post-cholecystectomy outcomes. Future clinical studies should focus on exploring more objective variables for symptom resolution following cholecystectomy. Determinants for the development of symptomatic gallstones as identified in previous larger cohort studies (see Section 2) are candidate explorative variables for future studies [7,51,52,53]. Due to a consensus on the need for cholecystectomy in the treatment of symptomatic complicated gallstones in clinical practice guidelines, future studies should confine to populations of symptomatic uncomplicated gallstones. If determinants for symptom resolution following cholecystectomy are identified, future randomized controlled trials may explore selection strategies yet further to improve management strategies for the treatment of symptomatic uncomplicated gallstones.

10. Conclusions

Studies exploring symptomatic outcomes following cholecystectomy mostly include heterogeneous populations with a variety of clinical gallstone presentations. Further, they fail to report a diagnostic workup or treatment for post-cholecystectomy symptoms. This challenges the comparison of symptomatic outcomes between studies. Although biliary pain seems to resolve following cholecystectomy in most patients, dyspeptic symptoms may co-exist with pain and may both resolve or develop following cholecystectomy. Patient satisfaction following cholecystectomy is high, which may reflect a symptom alleviation or, alternatively, a change in symptoms. Persisting complaints following surgery are mostly determined by preoperative functional disorders, atypical pain locations, long duration of symptoms, frequent and long pain episodes, and poor psychological or physical health. Even when the selection of patients for cholecystectomy is restricted to the presence of biliary pain, unacceptably high proportions of patients have persisting pain. Biliary pain is ill-defined and mostly based on consensus statements, but it currently remains the only criterion for cholecystectomy in the presence of symptomatic uncomplicated gallstones. The exploration of patient-reported symptoms only for the prediction of cholecystectomy symptomatic outcome has been exhausted. Future prospective clinical studies should explore the impact of objective determinants for symptomatic gallstones on pain resolution following cholecystectomy in patients with presumed symptomatic uncomplicated gallstones.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Lunevicius, R.; Nzenwa, I.C.; Mesri, M. A nationwide analysis of gallbladder surgery in England between 2000 and 2019. Surgery 2022, 171, 276–284. [Google Scholar] [CrossRef] [PubMed]
  2. Bray, F.; Balcaen, T.; Baro, E.; Gandon, A.; Ficheur, G.; Chazard, E. Increased incidence of cholecystectomy related to gallbladder disease in France: Analysis of 807,307 cholecystectomy procedures over a period of seven years. J. Visc. Surg. 2019, 156, 209–215. [Google Scholar] [CrossRef] [PubMed]
  3. Zdanowicz, K.; Daniluk, J.; Lebensztejn, D.M.; Daniluk, U. The Etiology of Cholelithiasis in Children and Adolescents—A Literature Review. Int. J. Mol. Sci. 2022, 23, 13376. [Google Scholar] [CrossRef] [PubMed]
  4. Peery, A.F.; Crockett, S.D.; Murphy, C.C.; Jensen, E.T.; Kim, H.P.; Egberg, M.D.; Lund, J.L.; Moon, A.M.; Pate, V.; Barnes, E.L.; et al. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021. Gastroenterology 2022, 162, 621–644. [Google Scholar] [CrossRef] [PubMed]
  5. Lamberts, M.P.; Lugtenberg, M.; Rovers, M.M.; Roukema, A.J.; Drenth, J.P.; Westert, G.P.; van Laarhoven, C.J. Persistent and de novo symptoms after cholecystectomy: A systematic review of cholecystectomy effectiveness. Surg. Endosc. 2013, 27, 709–718. [Google Scholar] [CrossRef] [PubMed]
  6. Stinton, L.M.; Shaffer, E.A. Epidemiology of gallbladder disease: Cholelithiasis and cancer. Gut Liver 2012, 6, 172–187. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Shabanzadeh, D.M.; Sorensen, L.T.; Jorgensen, T. A Prediction Rule for Risk Stratification of Incidentally Discovered Gallstones: Results from a Large Cohort Study. Gastroenterology 2016, 150, 156–167.e1. [Google Scholar] [CrossRef]
  8. Portincasa, P.; Di Ciaula, A.; de Bari, O.; Garruti, G.; Palmieri, V.O.; Wang, D.Q. Management of gallstones and its related complications. Expert Rev. Gastroenterol. Hepatol. 2016, 10, 93–112. [Google Scholar] [CrossRef]
  9. National Institute for Health and Care Excellence (NICE). Gallstone Disease: Diagnosis and Management of Cholelithiasis, Cholecystitis and Choledocholithiasis. In National Institute for Health and Care Excellence: Guidelines; National Institute for Health and Care Excellence (NICE): London, UK, 2014. Available online: https://www.ncbi.nlm.nih.gov/books/NBK327525/?report=reader (accessed on 27 February 2023).
  10. European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones. J. Hepatol. 2016, 65, 146–181. [Google Scholar] [CrossRef] [Green Version]
  11. de Boer, E.; Boerma, D.; van Erpecum, K.J.; Hermans, J.J.; Lamberts, M.P.; Rauws, E.A.J.; Schreinemakers, J.M.J.; van Laarhoven, C.J.H.M. Dutch Guidelines for Treatment of Gallstones (Galsteenlijden); Nederlandse Vereniging voor Heelkunde: Utrecht, The Netherlands, 2017. [Google Scholar]
  12. Gutt, C.; Jenssen, C.; Barreiros, A.P.; Gotze, T.O.; Stokes, C.S.; Jansen, P.L.; Neubrand, M.; Lammert, F. Updated S3-Guideline for Prophylaxis, Diagnosis and Treatment of Gallstones. German Society for Digestive and Metabolic Diseases (DGVS) and German Society for Surgery of the Alimentary Tract (DGAV)—AWMF Registry 021/008. Z. Gastroenterol. 2018, 56, 912–966. [Google Scholar] [CrossRef] [Green Version]
  13. Shabanzadeh, D.M.; Christensen, D.W.; Ewertsen, C.; Friis-Andersen, H.; Helgstrand, F.; Nannestad Jørgensen, L.; Kirkegaard-Klitbo, A.; Larsen, A.C.; Ljungdalh, J.S.; Nordblad Schmidt, P.; et al. National clinical practice guidelines for the treatment of symptomatic gallstone disease: 2021 recommendations from the Danish Surgical Society. Scand. J. Surg. 2022, 111, 11–30. [Google Scholar] [CrossRef] [PubMed]
  14. Napolitano, L.M.; Alam, H.B.; Biesterveld, B.E.; Gemmete, J.J.; Kronick, S.L.; Pomerantz, B.; Repaskey, W.T.; Rice, M.D.; Mack, M.R.; Proudlock, A.; et al. Evaluation and Management of Gallstone-Related Diseases in Non-Pregnant Adults. In Evaluation and Management of Gallstone-Related Diseases in Non-Pregnant Adults; Michigan Medicine Clinical Care Guidelines; University of Michigan: Ann Arbor, MI, USA, 2014. [Google Scholar]
  15. Commissioning Guide: Gallstone Disease; Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, The Royal College of Surgeons of England: London, UK, 2016.
  16. Vetrhus, M.; Soreide, O.; Solhaug, J.H.; Nesvik, I.; Sondenaa, K. Symptomatic, non-complicated gallbladder stone disease. Operation or observation? A randomized clinical study. Scand. J. Gastroenterol. 2002, 37, 834–839. [Google Scholar] [CrossRef] [PubMed]
  17. Schmidt, M.; Sondenaa, K.; Vetrhus, M.; Berhane, T.; Eide, G.E. A randomized controlled study of uncomplicated gallstone disease with a 14-year follow-up showed that operation was the preferred treatment. Dig. Surg. 2011, 28, 270–276. [Google Scholar] [CrossRef] [PubMed]
  18. Pucher, P.H.; Brunt, L.M.; Davies, N.; Linsk, A.; Munshi, A.; Rodriguez, H.A.; Fingerhut, A.; Fanelli, R.D.; Asbun, H.; Aggarwal, R.; et al. Outcome trends and safety measures after 30 years of laparoscopic cholecystectomy: A systematic review and pooled data analysis. Surg. Endosc. 2018, 32, 2175–2183. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Latenstein, C.S.S.; Wennmacker, S.Z.; de Jong, J.J.; van Laarhoven, C.; Drenth, J.P.H.; de Reuver, P.R. Etiologies of Long-Term Postcholecystectomy Symptoms: A Systematic Review. Gastroenterol. Res. Pract. 2019, 2019, 4278373. [Google Scholar] [CrossRef]
  20. Cox, M.R.; Budge, J.P.; Eslick, G.D. Timing and nature of presentation of unsuspected retained common bile duct stones after laparoscopic cholecystectomy: A retrospective study. Surg. Endosc. 2015, 29, 2033–2038. [Google Scholar] [CrossRef]
  21. Isherwood, J.; Oakland, K.; Khanna, A. A systematic review of the aetiology and management of post cholecystectomy syndrome. Surgeon 2019, 17, 33–42. [Google Scholar] [CrossRef]
  22. Gilliland, T.M.; Traverso, L.W. Modern standards for comparison of cholecystectomy with alternative treatments for symptomatic cholelithiasis with emphasis on long-term relief of symptoms. Surg. Gynecol. Obstet. 1990, 170, 39–44. [Google Scholar]
  23. McMahon, A.J.; Ross, S.; Baxter, J.N.; Russell, I.T.; Anderson, J.R.; Morran, C.G.; Sunderland, G.T.; Galloway, D.J.; O’Dwyer, P.J. Symptomatic outcome 1 year after laparoscopic and minilaparotomy cholecystectomy: A randomized trial. Br. J. Surg. 1995, 82, 1378–1382. [Google Scholar] [CrossRef]
  24. Bodvall, B. Biliary distress following cholecystectomy. Tijdschr. Gastroenterol. 1967, 10, 11–32. [Google Scholar]
  25. Middelfart, H.V.; Kristensen, J.U.; Laursen, C.N.; Qvist, N.; Hojgaard, L.; Funch-Jensen, P.; Kehlet, H. Pain and dyspepsia after elective and acute cholecystectomy. Scand. J. Gastroenterol. 1998, 33, 10–14. [Google Scholar] [CrossRef] [PubMed]
  26. Wanjura, V.; Lundstrom, P.; Osterberg, J.; Rasmussen, I.; Karlson, B.M.; Sandblom, G. Gastrointestinal quality-of-life after cholecystectomy: Indication predicts gastrointestinal symptoms and abdominal pain. World J. Surg. 2014, 38, 3075–3081. [Google Scholar] [CrossRef] [PubMed]
  27. Zhang, J.; Lu, Q.; Ren, Y.F.; Dong, J.; Mu, Y.P.; Lv, Y.; Zhang, X.F. Factors relevant to persistent upper abdominal pain after cholecystectomy. HPB 2017, 19, 629–637. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Vander Velpen, G.C.; Shimi, S.M.; Cuschieri, A. Outcome after cholecystectomy for symptomatic gall stone disease and effect of surgical access: Laparoscopic v open approach. Gut 1993, 34, 1448–1451. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Victorzon, M.; Lundin, M.; Haglund, C.; Roberts, P.J.; Kellokumpu, I. Short and long term outcome after laparoscopic cholecystectomy. Ann. Chir. Gynaecol. 1999, 88, 259–263. [Google Scholar] [PubMed]
  30. Black, N.A.; Thompson, E.; Sanderson, C.F. Symptoms and health status before and six weeks after open cholecystectomy: A European cohort study.ECHSS Group. European Collaborative Health Services Study Group. Gut 1994, 35, 1301–1305. [Google Scholar] [CrossRef] [Green Version]
  31. Mertens, M.C.; De Vries, J.; Scholtes, V.P.; Jansen, P.; Roukema, J.A. Prospective 6 weeks follow-up post-cholecystectomy: The predictive value of pre-operative symptoms. J. Gastrointest. Surg. 2009, 13, 304–311. [Google Scholar] [CrossRef] [Green Version]
  32. Bagaria, D.; Kaman, L.; Roger, E.; Dahyia, D.; Singh, R.; Bhattacharya, A. Effect of laparoscopic cholecystectomy on gastric emptying and dyspepsia. Surg. Endosc. 2013, 27, 3116–3120. [Google Scholar] [CrossRef]
  33. Karmacharya, A.; Malla, B.R.; Joshi, H.N.; Gurung, R.B.; Rajbhandari, M. The predictive value of pre-operative symptoms including upper gastrointestinal endoscopy before laparoscopic cholecystectomy for elective symptomatic cholecystolithiasis. Kathmandu Univ. Med. J. (KUMJ) 2013, 11, 300–304. [Google Scholar] [CrossRef] [Green Version]
  34. Fenster, L.F.; Lonborg, R.; Thirlby, R.C.; Traverso, L.W. What symptoms does cholecystectomy cure? Insights from an outcomes measurement project and review of the literature. Am. J. Surg. 1995, 169, 533–538. [Google Scholar] [CrossRef]
  35. Traverso, L.W.; Lonborg, R.; Pettingell, K.; Fenster, L.F. Utilization of cholecystectomy-a prospective outcome analysis in 1325 patients. J. Gastrointest. Surg. 2000, 4, 1–5. [Google Scholar] [CrossRef] [PubMed]
  36. Finan, K.R.; Leeth, R.R.; Whitley, B.M.; Klapow, J.C.; Hawn, M.T. Improvement in gastrointestinal symptoms and quality of life after cholecystectomy. Am. J. Surg. 2006, 192, 196–202. [Google Scholar] [CrossRef] [PubMed]
  37. Berger, M.Y.; Olde Hartman, T.C.; van der Velden, J.J.; Bohnen, A.M. Is biliary pain exclusively related to gallbladder stones? A controlled prospective study. Br. J. Gen. Pract. 2004, 54, 574–579. [Google Scholar] [PubMed]
  38. Osler, W. The Principles and Practice of Medicine; Appleton: New York, NY, USA, 1909. [Google Scholar]
  39. Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO). Prevalence of gallstone disease in an Italian adult female population. Am. J. Epidemiol. 1984, 119, 796–805. [Google Scholar] [CrossRef]
  40. Loria, P.; Dilengite, M.A.; Bozzoli, M.; Carubbi, F.; Messora, R.; Sassatelli, R.; Bertolotti, M.; Tampieri, A.; Tartoni, P.L.; Cassinadri, M.; et al. Prevalence rates of gallstone disease in Italy. The Chianciano population study. Eur. J. Epidemiol. 1994, 10, 143–150. [Google Scholar] [CrossRef]
  41. Attili, A.F.; Carulli, N.; Roda, E.; Barbara, B.; Capocaccia, L.; Menotti, A.; Okoliksanyi, L.; Ricci, G.; Capocaccia, R.; Festi, D.; et al. Epidemiology of gallstone disease in Italy: Prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.). Am. J. Epidemiol. 1995, 141, 158–165. [Google Scholar] [CrossRef]
  42. Ros, E.; Zambon, D. Postcholecystectomy symptoms. A prospective study of gall stone patients before and two years after surgery. Gut 1987, 28, 1500–1504. [Google Scholar] [CrossRef] [Green Version]
  43. Mertens, M.C.; Roukema, J.A.; Scholtes, V.P.; De Vries, J. Risk assessment in cholelithiasis: Is cholecystectomy always to be preferred? J. Gastrointest. Surg. 2010, 14, 1271–1279. [Google Scholar] [CrossRef] [Green Version]
  44. Barbara, L.; Sama, C.; Morselli Labate, A.M.; Taroni, F.; Rusticali, A.G.; Festi, D.; Sapio, C.; Roda, E.; Banterle, C.; Puci, A.; et al. A population study on the prevalence of gallstone disease: The Sirmione Study. Hepatology 1987, 7, 913–917. [Google Scholar] [CrossRef]
  45. Heaton, K.W.; Braddon, F.E.; Mountford, R.A.; Hughes, A.O.; Emmett, P.M. Symptomatic and silent gall stones in the community. Gut 1991, 32, 316–320. [Google Scholar] [CrossRef] [Green Version]
  46. Martinez de Pancorbo, C.; Carballo, F.; Horcajo, P.; Aldeguer, M.; de la Villa, I.; Nieto, E.; Gaspar, M.J.; de la Morena, J. Prevalence and associated factors for gallstone disease: Results of a population survey in Spain. J. Clin. Epidemiol. 1997, 50, 1347–1355. [Google Scholar] [CrossRef] [PubMed]
  47. Berger, M.Y.; van der Velden, J.J.; Lijmer, J.G.; de Kort, H.; Prins, A.; Bohnen, A.M. Abdominal symptoms: Do they predict gallstones? A systematic review. Scand. J. Gastroenterol. 2000, 35, 70–76. [Google Scholar] [PubMed]
  48. Shabanzadeh, D.M.; Sorensen, L.T.; Jorgensen, T. Which Abdominal Symptoms are Associated with Clinical Events in a Population Unaware of Their Gallstones? A Cohort Study. J. Gastrointest. Surg. 2017, 21, 831–839. [Google Scholar] [CrossRef] [PubMed]
  49. Galatola, G.; Jazrawi, R.P.; Kupfer, R.M.; Maudgal, D.P.; Lanzini, A.; Northfield, A.E.J. Value of different symptom complexes for clinical diagnosis of gallstones in outpatients presenting with abdominal pain. Eur. J. Gastroenterol. Hepatol. 1991, 3, 623–625. [Google Scholar]
  50. Shabanzadeh, D.M.; Sorensen, L.T.; Jorgensen, T. Abdominal Symptoms and Incident Gallstones in a Population Unaware of Gallstone Status. Can. J. Gastroenterol. Hepatol. 2016, 2016, 9730687. [Google Scholar] [CrossRef] [Green Version]
  51. Morris-Stiff, G.; Sarvepalli, S.; Hu, B.; Gupta, N.; Lal, P.; Burke, C.A.; Garber, A.; McMichael, J.; Rizk, M.K.; Vargo, J.J.; et al. The Natural History of Asymptomatic Gallstones: A Longitudinal Study and Prediction Model. Clin. Gastroenterol. Hepatol. 2022, 21, 319–327.e4. [Google Scholar] [CrossRef]
  52. Festi, D.; Reggiani, M.L.; Attili, A.F.; Loria, P.; Pazzi, P.; Scaioli, E.; Capodicasa, S.; Romano, F.; Roda, E.; Colecchia, A. Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. J. Gastroenterol. Hepatol. 2010, 25, 719–724. [Google Scholar] [CrossRef]
  53. Shabanzadeh, D.M.; Sorensen, L.T.; Jorgensen, T. Determinants for clinical events in gallstone carriers unaware of their gallstones. J. Gastroenterol. Hepatol. 2017, 32, 721–726. [Google Scholar] [CrossRef]
  54. Naunyn, B. A Treatise on Cholelithiasis; The New Sydenham Society: London, UK, 1892. [Google Scholar]
  55. Portincasa, P.; Moschetta, A.; Palasciano, G. Cholesterol gallstone disease. Lancet 2006, 368, 230–239. [Google Scholar] [CrossRef]
  56. Middelfart, H.V.; Jensen, P.; Hojgaard, L.; Funch-Jensen, P. Pain patterns after distension of the gallbladder in patients with acute cholecystitis. Scand. J. Gastroenterol. 1998, 33, 982–987. [Google Scholar] [CrossRef]
  57. Gunn, A.; Keddie, N. Some clinical observations on patients with gallstones. Lancet 1972, 2, 239–241. [Google Scholar] [CrossRef] [PubMed]
  58. Feretis, C.B.; Feretis, A.B.; Paisis, B.J.; Kontostavlaki, D.A.; Apostolidu, M.T.; Golematis, B.C. Managing dyspepsia in gallstone patients. Mt. Sinai J. Med. 1983, 50, 400–401. [Google Scholar] [PubMed]
  59. Bates, T.; Ebbs, S.R.; Harrison, M.; A’Hern, R.P. Influence of cholecystectomy on symptoms. Br. J. Surg. 1991, 78, 964–967. [Google Scholar] [CrossRef] [PubMed]
  60. Paul, A.; Troidl, H.; Gay, K.; Viell, B.; Bode, C. Dyspepsia and food intolerance in symptomatic gallstone disease. Does cholecystectomy help? Chir. Z. Alle Geb. Oper. Medizen 1991, 62, 462–466. [Google Scholar]
  61. Scriven, M.W.; Burgess, N.A.; Edwards, E.A.; Morgan, A.R.; Bundred, N.J.; Lewis, M.H. Cholecystectomy: A study of patient satisfaction. J. R. Coll. Surg. Edinb. 1993, 38, 79–81. [Google Scholar]
  62. Radecke, J.; Waninger, J.; Schlotterbeck, E.; Farthmann, E.H. Sequelae of cholecystectomy—A prospective study. Zent. Chir. 1993, 118, 337–341. [Google Scholar]
  63. Konsten, J.; Gouma, D.J.; von Meyenfeldt, M.F.; Menheere, P. Long-term follow-up after open cholecystectomy. Br. J. Surg. 1993, 80, 100–102. [Google Scholar] [CrossRef]
  64. Kane, R.L.; Lurie, N.; Borbas, C.; Morris, N.; Flood, S.; McLaughlin, B.; Nemanich, G.; Schultz, A. The outcomes of elective laparoscopic and open cholecystectomies. J. Am. Coll. Surg. 1995, 180, 136–145. [Google Scholar]
  65. Ure, B.M.; Troidl, H.; Spangenberger, W.; Lefering, R.; Dietrich, A.; Eypasch, E.P.; Neugebauer, E. Long-term results after laparoscopic cholecystectomy. Br. J. Surg. 1995, 82, 267–270. [Google Scholar] [CrossRef]
  66. Luman, W.; Adams, W.H.; Nixon, S.N.; McIntyre, I.M.; Hamer-Hodges, D.; Wilson, G.; Palmer, K.R. Incidence of persistent symptoms after laparoscopic cholecystectomy: A prospective study. Gut 1996, 39, 863–866. [Google Scholar] [CrossRef] [Green Version]
  67. Jess, P.; Jess, T.; Beck, H.; Bech, P. Neuroticism in relation to recovery and persisting pain after laparoscopic cholecystectomy. Scand. J. Gastroenterol. 1998, 33, 550–553. [Google Scholar] [PubMed]
  68. Borly, L.; Anderson, I.B.; Bardram, L.; Christensen, E.; Sehested, A.; Kehlet, H.; Matzen, P.; Rehfeld, J.F.; Stage, P.; Toftdahl, D.B.; et al. Preoperative prediction model of outcome after cholecystectomy for symptomatic gallstones. Scand. J. Gastroenterol. 1999, 34, 1144–1152. [Google Scholar] [CrossRef] [PubMed]
  69. Niranjan, B.; Chumber, S.; Kriplani, A.K. Symptomatic outcome after laparoscopic cholecystectomy. Trop. Gastroenterol. 2000, 21, 144–148. [Google Scholar] [PubMed]
  70. Weinert, C.R.; Arnett, D.; Jacobs, D., Jr.; Kane, R.L. Relationship between persistence of abdominal symptoms and successful outcome after cholecystectomy. Arch. Intern. Med. 2000, 160, 989–995. [Google Scholar] [CrossRef]
  71. Gad Elhak, N.; Abd Elwahab, M.; Nasif, W.A.; Abo-Elenein, A.; Abdalla, T.; el-Shobary, M.; Haleem, M.; Yaseen, A.; el-Ghawalby, N.; Ezzat, F. Prevalence of Helicobacter pylori, gastric myoelectrical activity, gastric mucosal changes and dyspeptic symptoms before and after laparoscopic cholecystectomy. Hepatogastroenterology 2004, 51, 485–490. [Google Scholar]
  72. Berhane, T.; Hausken, T.; Olafsson, S.; Sondenaa, K. Ultrasound examination shows disturbed proximal gastric function in symptomatic gallstone patients with dyspepsia and improvement after cholecystectomy--gallstones and gastric emptying. Ultraschall Med. 2006, 27, 451–455. [Google Scholar] [CrossRef]
  73. Larsen, T.K.; Qvist, N. The influence of gallbladder function on the symptomatology in gallstone patients, and the outcome after cholecystectomy or expectancy. Dig. Dis. Sci. 2007, 52, 760–763. [Google Scholar] [CrossRef]
  74. Halldestam, I.; Kullman, E.; Borch, K. Defined indications for elective cholecystectomy for gallstone disease. Br. J. Surg. 2008, 95, 620–626. [Google Scholar] [CrossRef]
  75. Amir, M.; Zubair, M. Influence of cholecystectomy on symptomatic cholelithiasis: Can all symptoms be improved? Rawal Med. J. 2009, 34, 141–144. [Google Scholar]
  76. Mehrvarz, S.; Fanaei, S.; Ziaee, A. The role of laparoscopic cholecystectomy in alleviating gastrointestinal symptoms. Int. J. Med. Med. Sci. 2010, 2, 153–157. [Google Scholar]
  77. Thistle, J.L.; Longstreth, G.F.; Romero, Y.; Arora, A.S.; Simonson, J.A.; Diehl, N.N.; Harmsen, W.S.; Zinsmeister, A.R. Factors that predict relief from upper abdominal pain after cholecystectomy. Clin. Gastroenterol. Hepatol. 2011, 9, 891–896. [Google Scholar] [CrossRef] [PubMed]
  78. Latenstein, C.S.S.; Hannink, G.; van der Bilt, J.D.W.; Donkervoort, S.C.; Eijsbouts, Q.A.J.; Heisterkamp, J.; Nieuwenhuijs, V.B.; Schreinemakers, J.M.J.; Wiering, B.; Boermeester, M.A.; et al. A Clinical Decision Tool for Selection of Patients with Symptomatic Cholelithiasis for Cholecystectomy Based on Reduction of Pain and a Pain-Free State Following Surgery. JAMA Surg. 2021, 156, e213706. [Google Scholar] [CrossRef] [PubMed]
  79. de Jong, J.J.; Latenstein, C.S.S.; Boerma, D.; Hazebroek, E.J.; Hirsch, D.; Heikens, J.T.; Konsten, J.; Polat, F.; Lantinga, M.A.; van Laarhoven, C.; et al. Functional Dyspepsia and Irritable Bowel Syndrome are Highly Prevalent in Patients with Gallstones and Are Negatively Associated with Outcomes after Cholecystectomy: A Prospective, Multicenter, Observational Study (PERFECT—Trial). Ann. Surg. 2022, 275, e766–e772. [Google Scholar] [CrossRef]
  80. Ibrarullah, M.; Mittal, B.R.; Agarwal, D.K.; Das, B.K.; Kaushik, S.P. Gastric emptying in patients with gallstone disease with or without dyspepsia: Effect of cholecystectomy. Aust. N. Z. J. Surg. 1994, 64, 247–250. [Google Scholar] [CrossRef]
  81. Lorusso, D.; Porcelli, P.; Pezzolla, F.; Lantone, G.; Zivoli, G.; Guerra, V.; Misciagna, G.; Demma, I. Persistent dyspepsia after laparoscopic cholecystectomy. The influence of psychological factors. Scand. J. Gastroenterol. 2003, 38, 653–658. [Google Scholar] [CrossRef]
  82. Vignolo, M.C.; Savassi-Rocha, P.R.; Coelho, L.G.; Soares, M.P.; Cardoso-Junior, A.; Barbosa, T.F.; Ramos, F.V.; Alves, T.R.; Barbosa, G.M.; Pinto, D.C.; et al. Gastric emptying before and after cholecystectomy in patients with cholecystolithiasis. Hepatogastroenterology 2008, 55, 850–854. [Google Scholar]
  83. Jorgensen, T.; Teglbjerg, J.S.; Wille-Jorgensen, P.; Bille, T.; Thorvaldsen, P. Persisting pain after cholecystectomy: A prospective investigation. Scand. J. Gastroenterol. 1991, 26, 124–128. [Google Scholar] [CrossRef]
  84. Mjaland, O.; Hogevold, H.E.; Buanes, T. Standard preoperative assessment can improve outcome after cholecystectomy. Eur. J. Surg. 2000, 166, 129–135. [Google Scholar] [CrossRef]
  85. Schmidt, M.; Sondenaa, K.; Dumot, J.A.; Rosenblatt, S.; Hausken, T.; Ramnefjell, M.; Njolstad, G.; Eide, G.E. Post-cholecystectomy symptoms were caused by persistence of a functional gastrointestinal disorder. World J. Gastroenterol. 2012, 18, 1365–1372. [Google Scholar] [CrossRef]
  86. Lamberts, M.P.; Den Oudsten, B.L.; Keus, F.; De Vries, J.; van Laarhoven, C.J.; Westert, G.P.; Drenth, J.P.; Roukema, J.A. Patient-reported outcomes of symptomatic cholelithiasis patients following cholecystectomy after at least 5 years of follow-up: A long-term prospective cohort study. Surg. Endosc. 2014, 28, 3443–3450. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Wennmacker, S.; Lamberts, M.; Gerritsen, J.; Roukema, J.A.; Westert, G.; Drenth, J.; van Laarhoven, C. Consistency of patient-reported outcomes after cholecystectomy and their implications on current surgical practice: A prospective multicenter cohort study. Surg. Endosc. 2017, 31, 215–224. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  88. Stefanini, P.; Carboni, M.; Patrassi, N.; Loriga, P.; De Bernardinis, G.; Negro, P. Factors influencing the long term results of cholecystectomy. Surg. Gynecol. Obstet. 1974, 139, 734–738. [Google Scholar] [PubMed]
  89. Jazrawi, S.; Walsh, T.N.; Byrne, P.J.; Hill, A.D.; Li, H.; Lawlor, P.; Hennessy, T.P. Cholecystectomy and oesophageal reflux: A prospective evaluation. Br. J. Surg. 1993, 80, 50–53. [Google Scholar] [CrossRef]
  90. Manifold, D.K.; Anggiansah, A.; Owen, W.J. Effect of cholecystectomy on gastroesophageal and duodenogastric reflux. Am. J. Gastroenterol. 2000, 95, 2746–2750. [Google Scholar] [CrossRef]
  91. Peterli, R.; Schuppisser, J.P.; Herzog, U.; Ackermann, C.; Tondelli, P.E. Prevalence of postcholecystectomy symptoms: Long-term outcome after open versus laparoscopic cholecystectomy. World J. Surg. 2000, 24, 1232–1235. [Google Scholar] [CrossRef]
  92. Fisher, M.; Spilias, D.C.; Tong, L.K. Diarrhoea after laparoscopic cholecystectomy: Incidence and main determinants. ANZ J. Surg. 2008, 78, 482–486. [Google Scholar] [CrossRef] [PubMed]
  93. Kim, G.H.; Lee, H.D.; Kim, M.; Kim, K.; Jeong, Y.; Hong, Y.J.; Kang, E.S.; Han, J.H.; Choi, J.W.; Park, S.M. Fate of dyspeptic or colonic symptoms after laparoscopic cholecystectomy. J. Neurogastroenterol. Motil. 2014, 20, 253–260. [Google Scholar] [CrossRef] [Green Version]
  94. Vetrhus, M.; Berhane, T.; Soreide, O.; Sondenaa, K. Pain persists in many patients five years after removal of the gallbladder: Observations from two randomized controlled trials of symptomatic, noncomplicated gallstone disease and acute cholecystitis. J. Gastrointest. Surg. 2005, 9, 826–831. [Google Scholar] [CrossRef]
  95. Barker, J.R.; Alexander-Williams, J. The effect of cholecystectomy on oesophageal symptoms. Br. J. Surg. 1974, 61, 346–348. [Google Scholar] [CrossRef]
  96. Jasim, H. Postcholecystectomy bowel motion changes and diarrhea a prospective study. Iraqi Med. J. 2018, 64, 9–15. [Google Scholar]
  97. Plaisier, P.W.; van der Hul, R.L.; Nijs, H.G.; den Toom, R.; Terpstra, O.T.; Bruining, H.A. The course of biliary and gastrointestinal symptoms after treatment of uncomplicated symptomatic gallstones: Results of a randomized study comparing extracorporeal shock wave lithotripsy with conventional cholecystectomy. Am. J. Gastroenterol. 1994, 89, 739–744. [Google Scholar] [PubMed]
  98. Kingston, R.D.; Windsor, C.W. Flatulent dyspepsia in patients with gallstones undergoing cholecystectomy. Br. J. Surg. 1975, 62, 231–233. [Google Scholar] [CrossRef] [PubMed]
  99. Johnson, A.G.; Jenkins, A. Flatulent dyspepsia: A tiered symptom complex? Med. Hypotheses 1975, 1, 204–206. [Google Scholar] [CrossRef] [PubMed]
  100. Stanghellini, V.; Chan, F.K.; Hasler, W.L.; Malagelada, J.R.; Suzuki, H.; Tack, J.; Talley, N.J. Gastroduodenal Disorders. Gastroenterology 2016, 150, 1380–1392. [Google Scholar] [CrossRef]
  101. Lorusso, D.; Misciagna, G.; Mangini, V.; Messa, C.; Cavallini, A.; Caruso, M.L.; Giorgio, P.; Guerra, V. Duodenogastric reflux of bile acids, gastrin and parietal cells, and gastric acid secretion before and 6 months after cholecystectomy. Am. J. Surg. 1990, 159, 575–578. [Google Scholar] [CrossRef]
  102. Aprea, G.; Canfora, A.; Ferronetti, A.; Giugliano, A.; Guida, F.; Braun, A.; Battaglini Ciciriello, M.; Tovecci, F.; Mastrobuoni, G.; Cardin, F.; et al. Morpho-functional gastric pre-and post-operative changes in elderly patients undergoing laparoscopic cholecystectomy for gallstone related disease. BMC Surg. 2012, 12 (Suppl. S1), S5. [Google Scholar] [CrossRef] [Green Version]
  103. Atak, I.; Ozdil, K.; Yucel, M.; Caliskan, M.; Kilic, A.; Erdem, H.; Alimoglu, O. The effect of laparoscopic cholecystectomy on the development of alkaline reflux gastritis and intestinal metaplasia. Hepatogastroenterology 2012, 59, 59–61. [Google Scholar] [CrossRef]
  104. Di Ciaula, A.; Molina-Molina, E.; Bonfrate, L.; Wang, D.Q.; Dumitrascu, D.L.; Portincasa, P. Gastrointestinal defects in gallstone and cholecystectomized patients. Eur. J. Clin. Investig. 2019, 49, e13066. [Google Scholar] [CrossRef] [Green Version]
  105. Hearing, S.D.; Thomas, L.A.; Heaton, K.W.; Hunt, L. Effect of cholecystectomy on bowel function: A prospective, controlled study. Gut 1999, 45, 889–894. [Google Scholar] [CrossRef] [Green Version]
  106. Sauter, G.H.; Moussavian, A.C.; Meyer, G.; Steitz, H.O.; Parhofer, K.G.; Jungst, D. Bowel habits and bile acid malabsorption in the months after cholecystectomy. Am. J. Gastroenterol. 2002, 97, 1732–1735. [Google Scholar] [CrossRef]
  107. Sciarretta, G.; Furno, A.; Mazzoni, M.; Malaguti, P. Post-cholecystectomy diarrhea: Evidence of bile acid malabsorption assessed by SeHCAT test. Am. J. Gastroenterol. 1992, 87, 1852–1854. [Google Scholar] [PubMed]
  108. Fort, J.M.; Azpiroz, F.; Casellas, F.; Andreu, J.; Malagelada, J.R. Bowel habit after cholecystectomy: Physiological changes and clinical implications. Gastroenterology 1996, 111, 617–622. [Google Scholar] [CrossRef] [PubMed]
  109. Li, Y.D.; Liu, B.N.; Zhao, S.H.; Zhou, Y.L.; Bai, L.; Liu, E.Q. Changes in gut microbiota composition and diversity associated with post-cholecystectomy diarrhea. World J. Gastroenterol. 2021, 27, 391–403. [Google Scholar] [CrossRef] [PubMed]
  110. Xu, Y.; Jing, H.; Wang, J.; Zhang, S.; Chang, Q.; Li, Z.; Wu, X.; Zhang, Z. Disordered Gut Microbiota Correlates with Altered Fecal Bile Acid Metabolism and Post-cholecystectomy Diarrhea. Front. Microbiol. 2022, 13, 800604. [Google Scholar] [CrossRef] [PubMed]
  111. Ruiz-Campos, L.; Gisbert, J.P.; Ysamat, M.; Arau, B.; Loras, C.; Esteve, M.; Fernandez-Banares, F. Systematic review with meta-analysis: The prevalence of bile acid malabsorption and response to colestyramine in patients with chronic watery diarrhoea and previous cholecystectomy. Aliment. Pharmacol. Ther. 2019, 49, 242–250. [Google Scholar] [CrossRef]
  112. Farrugia, A.; Attard, J.A.; Hanmer, S.; Bullock, S.; McKay, S.; Al-Azzawi, M.; Ali, R.; Bond-Smith, G.; Colleypriest, B.; Dyer, S.; et al. Rates of Bile Acid Diarrhoea after Cholecystectomy: A Multicentre Audit. World J. Surg. 2021, 45, 2447–2453. [Google Scholar] [CrossRef]
  113. Yueh, T.P.; Chen, F.Y.; Lin, T.E.; Chuang, M.T. Diarrhea after laparoscopic cholecystectomy: Associated factors and predictors. Asian J. Surg. 2014, 37, 171–177. [Google Scholar] [CrossRef] [Green Version]
  114. Manning, A.P.; Thompson, W.G.; Heaton, K.W.; Morris, A.F. Towards positive diagnosis of the irritable bowel. Br. Med. J. 1978, 2, 653–654. [Google Scholar] [CrossRef] [Green Version]
  115. Mearin, F.; Lacy, B.E.; Chang, L.; Chey, W.D.; Lembo, A.J.; Simren, M.; Spiller, R. Bowel Disorders. Gastroenterology 2016, 150, 1393–1407. [Google Scholar] [CrossRef] [Green Version]
  116. Kirk, G.; Kennedy, R.; McKie, L.; Diamond, T.; Clements, B. Preoperative symptoms of irritable bowel syndrome predict poor outcome after laparoscopic cholecystectomy. Surg. Endosc. 2011, 25, 3379–3384. [Google Scholar] [CrossRef]
  117. Corazziari, E.; Attili, A.F.; Angeletti, C.; De Santis, A. Gallstones, cholecystectomy and irritable bowel syndrome (IBS) MICOL population-based study. Dig. Liver Dis. 2008, 40, 944–950. [Google Scholar] [CrossRef] [PubMed]
  118. van Dijk, A.H.; Wennmacker, S.Z.; de Reuver, P.R.; Latenstein, C.S.S.; Buyne, O.; Donkervoort, S.C.; Eijsbouts, Q.A.J.; Heisterkamp, J.; Hof, K.I.; Janssen, J.; et al. Restrictive strategy versus usual care for cholecystectomy in patients with gallstones and abdominal pain (SECURE): A multicentre, randomised, parallel-arm, non-inferiority trial. Lancet 2019, 393, 2322–2330. [Google Scholar] [CrossRef] [PubMed]
Table
Table 2. Determinants of postoperative symptoms identified in prospective clinical studies.
Table 2. Determinants of postoperative symptoms identified in prospective clinical studies.
Postoperative OutcomePreoperative Determinant
Symptom resolutionPrevious cholecystitis [70]
Higher age [62]
Pain resolutionNo heartburn [78]
Lower visual analogue scale [78]
Pain attacks [78]
Pain awakening at night [77]
Pain frequency ≤ 1 per month [77]
Symptom duration ≤ 1 year [77,87]
No use of pain medication [78]
No previous abdominal surgery [78]
Higher Gastrointestinal Quality of Life Index [87]
Higher age [77,78]
Persisting symptomsDyspeptic symptoms [63,70]
Symptom duration > 6 months [70]
Gastritis [93]
Poor self-rated health [70]
Higher Hopkins Symptom Checklist [81]
Gastrointestinal Symptom Rating Scale [81]
Higher trait anxiety [43]
Higher Psychological Symptom Score [93]
ASA III–IV [70]
PainDyspepsia [68]
Functional dyspepsia/irritable bowel syndrome [79]
Atypical pain locations/lower abdominal pain [74,77]
Flatulence [74]
Food intolerance [74]
Abnormal bowel pattern (diarrhea or constipation) [77]
Often feeling bloated [77]
Pain attacks every month [74]
Psychic vulnerability [83]
DyspepsiaDyspepsia [43,68]
Non-specific symptoms [43]
Psychotropic medication [43]
Middle age range (40–69 years) [95]
Unsatisfying/unsuccessful cholecystectomy outcomeFlatulence [59]
Pain episode duration of days or more [59]
Symptom duration > 6 months [70]
Poor self-rated health [70]
Age > 55 years [59]
Younger age [62]
DiarrheaAge < 50 years [92,96]
Higher body mass index group [96]
Table
Table 3. Symptomatic outcome following cholecystectomy in prospective studies.
Table 3. Symptomatic outcome following cholecystectomy in prospective studies.
Preoperative Proportion (%)DeclineInclineDebuting
Pain attacks/biliary colic/biliary pain42–100%↓↓↓–(0%)
Unspecified/atypical pain9–100%↓↓ ↑0–7%
Dyspepsia11–88%↓↓(↑↑↑)0–6%
Heartburn 25–66%↓↓–1–8%
Regurgitation/reflux11–72%↓↓ (↑)2–14%
Nausea13–90%↓↓↓(↑↑↑)0–2%
Vomiting7–54%↓↓↓(↑↑↑)0–1%
Fat or food intolerance36–80%↓↓↓–2–13%
Indigestion/postprandial heaviness14–78%↓↓ ––
Flatulence15–88%↓–0–10%
Diarrhea2–22%(→)↑↑↑ 14–17%
Bloating/distension 37–82%↓↓ ––
Constipation7–65%→––
Arrows indicate % change in proportion of patients reporting symptoms before versus after cholecystectomy as reported in most studies. ↓↓↓/↑↑↑ decline/incline of 60% or more; ↓↓/↑↑ decline/incline of 30–60% or more; ↓/↑ decline/incline of 30–60%; → % change less than 30%; – indicates no available studies or incomparable estimates between studies; () indicates estimates from single studies.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Shabanzadeh, D.M. The Symptomatic Outcomes of Cholecystectomy for Gallstones. J. Clin. Med. 2023, 12, 1897. https://doi.org/10.3390/jcm12051897

AMA Style

Shabanzadeh DM. The Symptomatic Outcomes of Cholecystectomy for Gallstones. Journal of Clinical Medicine. 2023; 12(5):1897. https://doi.org/10.3390/jcm12051897

Chicago/Turabian Style

Shabanzadeh, Daniel Mønsted. 2023. "The Symptomatic Outcomes of Cholecystectomy for Gallstones" Journal of Clinical Medicine 12, no. 5: 1897. https://doi.org/10.3390/jcm12051897

APA Style

Shabanzadeh, D. M. (2023). The Symptomatic Outcomes of Cholecystectomy for Gallstones. Journal of Clinical Medicine, 12(5), 1897. https://doi.org/10.3390/jcm12051897

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop